openPR Logo
Press release

Batten Disease Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

04-25-2018 04:24 PM CET | Health & Medicine

Press release from: Pharmaceutical Report

Batten Disease Treatment Market - Global Industry Insights,

Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of genes resulting in their inability to synthesize required protein. This disease is characterized by malfunctioning of body, which usually appears around the age of 2-10 with symptoms, such as seizures or gradual onset of vision problem. The early signs may show subtle changes in behavior and learning, however over time, the child suffers from mental impairment, progressive loss of sight, speech and motor reactions, worsening seizures, eventually leading to blindness dementia, and finally death. These disease is diagnosed with the help of certain tests, such as blood or urine tests, skin or tissue dampening, brain scans, and imaging techniques, which includes, computed tomography (CT) or magnetic resonance imaging (MRI). The batten disease is characterized into four types as follows:

Infantile NCL: more than 2 years

Late Infantile NCL: 2-4 years (Life span of child varies between 8-12 years)

Juvenile NCL: 5-8 years (Life span varies between teens to early 20s)

Adult NCL: more than 40 years (Variable lifespan)

Request for a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/831

European countries facing rising prevalence and incidence of batten disease

According to the Centers for Disease Control and Prevention (CDC), Batten disease is observed in 2-4 per 100,000 live births in the United States on an average. The Batten disease although is rare but has high incidence rates in Finland, Sweden, and other parts of the Europe as compared to rest of the world. According to the Batten Disease Support and Research Association, the batten disease has often been encountered in more than one children of the same family. The Daily News and Analysis article published in June 2016 suggests that, over 20 million children in India suffer from rare diseases, having expensive treatments. This creates opportunities for the sustaining as well as upcoming market players by understanding the potential held by the global batten disease treatment market.

The global batten disease treatment market is segmented on the basis of therapy and geographical regions.

On the basis of therapy, the global batten disease treatment market is segmented as

Occupational Therapies,Physical Therapies,.

As of now, there are no established drugs and treatments to cure and prevent the disease. However, the severity of disease can be reduced and controlled by certain therapies. Few clinical trials and studies are being carried out in the North America, Western Europe, and Asia Pacific to identify therapies that would help reducing the disease outcome.

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/831

Attempts by collaborations of research bodies for introduction to reliable treatment options for batten disease giving hopes to commoners

The batten disease treatment market is not dense on the global level, however the developed economies of North America and Europe are expected to contribute to the growth of the market. This attributes to the increasing incidence of batten disease and high prevalence rates in American as well as European countries. For instance, a joint study between Baylor College of Medicine, Texas Children’s Hospital, and King’s College London have discovered a treatment that has helped to improve the neurological symptoms in the mouse model of juvenile batten disease. This research held a novel approach of counteracting the accumulation of the cellular waste in Batten disease by acting on TFEB, which is a master transcription factor that stimulates the production of lysosomes by the cell body and directs cellular apoptosis. This has brought a ray of hope to patients and families affected by battens disease.

Improper treatment facility for batten disease responsible to attract the attention of various players to enter the untapped potential batten disease treatment market

The rising incidence of the batten disease without effective treatment option for the prevention and cure of the disease is the primary driver for batten disease market, due to which several companies are vying to enter into the untapped global batten disease treatment market. However, the lack of awareness among manufacturers and patient population as well as unavailability of treatment for this disease are greatly hampering the growth of the global batten disease treatment market.

Although, the global batten disease treatment market is very scarce, few key players offering cell regeneration therapies and few other forms of medication include Seneb BioSciences, Inc., BioMarin Pharmaceuticals and ReGenX Biosciences LLC. The U.S. FDA has recently approved BioMarin’s first ever drug to treat batten disease known as Brineura in 2017.

Complete Report Details @ https://www.coherentmarketinsights.com/ongoing-insight/batten-disease-treatment-market-831

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,
#3200
Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Batten Disease Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025 here

News-ID: 1030644 • Views: 699

More Releases from Pharmaceutical Report

Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Human Chorionic Gonadotropin (HCG) Market to Rear Excessive Growth During 2016 …
Human chorionic gonadotropin hormone (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. The HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males mostly to increase the sperm count and in young
Medical Waste Management Market, By Services, and By Techniques - Global Industr …
Healthcare activities generates a lot of waste, especially from the frequently used consumables, which are harmful for in-patients and healthy population. Medical waste includes waste generated within research centers and health-care facilities for example, sharps waste, infectious waste, pathological waste, pharmaceutical waste, chemical waste, and radioactive waste. The waste product that are generated by the healthcare activities have higher potential to spread infection and injuries. Inadequate or incorrect handling of
Insomnia therapeutics Market By Drug Class, and Distribution Channel
Insomnia is a common type of sleep disorder and frequently co-morbid with mental or psychiatric illness. Consistent risk factors for insomnia are age, and stress associated with job, family, financial, and medical conditions. Increase in consumption of alcohol, caffeine, nicotine could also lead to insomnia. Depending on the duration, insomnia is categorized into transient and chronic insomnia. Transient insomnia last for a single night to few weeks or months and

All 5 Releases


More Releases for Batten

Batten Disease Treatment Market Report Up to 2031
Visiongain has published a new report on Batten Disease Treatment Market Report to 2031. Profiles of Leading Batten Disease Treatment Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. The global Batten Disease Treatment market has been growing considerably owing to the rising incidence and prevalence rate of batten disease, technological advancement, and significant investment in the R&D process. Further, the growing clinical trials and increasing pipeline products
Batten Disease Treatment Market 2020 Showing Impressive Growth
The "Global Batten Disease Treatment Market Set for Rapid Growth to Reach Around USD 41.39 by 2023", report intends to offer a resourceful means to assess the Batten Disease Treatment Market and entails the all-inclusive analysis and upfront statistics with regards to the market. This new report is committed fulfilling the requirements of the clients by giving them thorough insights into the market. The Batten Disease Treatment Market report, titled
Global Batten Disease Treatment Market 2019| BioMarin Pharmaceuticals, Seneb Bio …
This research report titled “Global Batten Disease Treatment Market” Size, Status and Forecast 2019-2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Batten Disease Treatment Market during the period between 2019 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities
Batten Disease Treatment Market Opportunity Analysis, 2018-2026
Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of
Batten Disease - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Batten Disease - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten Disease - Pipeline Review, H2 2017, provides an overview of the Batten Disease (Central Nervous System) pipeline landscape. Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorders known as
Batten Disease Treatment Market Trends Opportunity Analysis,2025
Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of